Intratect 100 ml. 5 g.

Replacement therapy in:
a) Primary immunodeficiency syndromes
b) Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
c) Children with congenital AIDS and recurrent infections
Immunomodulation
a) Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count
b) Guillain Barré syndrome
c) Kawasaki disease
Allogeneic bone marrow transplantation

Category:

Description

Replacement therapy in:
a) Primary immunodeficiency syndromes
b) Myeloma or chronic lymphocytic leukaemia with severe secondary hypogammaglobulinaemia and recurrent infections
c) Children with congenital AIDS and recurrent infections
Immunomodulation
a) Idiopathic thrombocytopenic purpura (ITP), in children or adults at high risk of bleeding or prior to surgery to correct the platelet count
b) Guillain Barré syndrome
c) Kawasaki disease
Allogeneic bone marrow transplantation